Trasidrex (A Fixed Combination of Slow Trasicor 160mg and Navidrex 0.25mg) in the Treatment of Hypertension: A Multicentre Clinical Trial in General Practice
- 1 November 1978
- journal article
- research article
- Published by SAGE Publications in Journal of International Medical Research
- Vol. 6 (6) , 494-498
- https://doi.org/10.1177/030006057800600615
Abstract
Sixty-two patients with hypertension who were treated with a free combination of Slow Trasicor or Trasicor and Navidrex K were transferred to a fixed combination tablet, Trasidrex (slow oxprenolol 160 mg + cyclopenthiazide 0.25 mg). Blood pressure control was marginally improved and there was no increase in side-effects.This publication has 1 reference indexed in Scilit:
- A symptom questionnaire for hypertensive patientsJournal of Chronic Diseases, 1974